Cargando…
Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database
BACKGROUND: Our study aimed to determine the risk of herpes zoster reactivation and coronavirus disease 2019 (COVID-19) vaccination (mRNA vaccine [BNT162b2] and adenovirus-vectored vaccine [ChAdOx1 nCoV-19]). METHODS: This retrospective study analyzed herpes zoster cases diagnosed between 26 Februar...
Autores principales: | Yoon, Jin Gu, Kim, Young-Eun, Choi, Min Joo, Choi, Won Suk, Seo, Yu Bin, Jung, Jaehun, Hyun, Hak-Jun, Seong, Hye, Nham, Eliel, Noh, Ji Yun, Song, Joon Young, Kim, Woo Joo, Kim, Dong Wook, Cheong, Hee Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640769/ https://www.ncbi.nlm.nih.gov/pubmed/37549237 http://dx.doi.org/10.1093/infdis/jiad297 |
Ejemplares similares
-
Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017) -
Physician Attitudes toward the Herpes Zoster Vaccination in South Korea
por: Yang, Tae Un, et al.
Publicado: (2014) -
Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Ulaszewska, Marta, et al.
Publicado: (2023) -
Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
por: Bruxvoort, Katia J, et al.
Publicado: (2022) -
COVID-19 Vaccination in Korea: Past, Present, and the Way Forward
por: Nham, Eliel, et al.
Publicado: (2022)